2019
DOI: 10.1111/cod.13290
|View full text |Cite
|
Sign up to set email alerts
|

Systemic allergic dermatitis after patch testing with cinchocaine (dibucaine) and topical corticosteroids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 14 publications
1
5
0
Order By: Relevance
“…Tetracaine‐HCl has been rarely reported as a cause of systemic allergic dermatitis due to systemic absorption from urethral 7,8 and rectal 9 mucosae and never from patch testing. Recently Alves da Silva et al described the case of systemic allergic dermatitis several days after patch testing in a patient sensitized to cinchocaine and corticosteroids 3 . The shorter latency observed in our patient could be due to the absence of allergy to corticosteroids, notably able to delay allergic reactions.…”
Section: % D2 D4supporting
confidence: 45%
See 1 more Smart Citation
“…Tetracaine‐HCl has been rarely reported as a cause of systemic allergic dermatitis due to systemic absorption from urethral 7,8 and rectal 9 mucosae and never from patch testing. Recently Alves da Silva et al described the case of systemic allergic dermatitis several days after patch testing in a patient sensitized to cinchocaine and corticosteroids 3 . The shorter latency observed in our patient could be due to the absence of allergy to corticosteroids, notably able to delay allergic reactions.…”
Section: % D2 D4supporting
confidence: 45%
“…Systemic allergic dermatitis is defined as systemic reactivation of allergic contact dermatitis (ACD) by generalized hematogenous dissemination due to ingestion, inhalation, or injection of the responsible contact allergen or a cross‐reacting compound 1 . However, generalized dissemination of ACD from the primary contact site via blood vessels is rarely described also for mucocutaneous contact 2 and only exceptionally due to patch testing 3 . Herein we report a case of systemic allergic dermatitis during tetracaine‐hydrochloride (HCl) patch testing.…”
Section: % D2 D4mentioning
confidence: 97%
“…We identified 12 SCD cases due to topical anaesthetics, as previously compiled by de Groot, 4 involving cinchocaine (8/12), tetracaine (3/12), and lidocaine (1/12). Most cases presented after perianal administration (9/12) and as symmetric drug‐related intertriginous and flexural exanthema (SDRIFE) and Baboon syndromes (7/12) 7–13 …”
Section: Discussionmentioning
confidence: 99%
“…67,68,[79][80][81] The most characteristic manifestation of systemic contact dermatitis is the so-called baboon syndrome. [82][83][84][85] It presents as diffuse pink or dark violet erythema of the buttocks and inner thighs (Fig. 5), like an inverted triangle or V-shaped, resembling the red bottom of a baboon, often accompanied by dermatitis in the axillae and sometimes other body folds.…”
Section: Systemic Contact Dermatitismentioning
confidence: 99%
“…The most characteristic manifestation of systemic contact dermatitis is the so-called baboon syndrome 82–85 . It presents as diffuse pink or dark violet erythema of the buttocks and inner thighs (Fig.…”
Section: Allergic Contact Dermatitis From Topical Drugsmentioning
confidence: 99%